pindolol

Pindolol-d7 is a deuterated compound of Pindolol. Pindolol has a CAS number of 13523-86-9. Pindolol is a moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity.

Bopindolol ((±)-Bopindolol) fumarate is an orally active β-adrenoceptor (ARs) antagonist with partial agonist activity, non-selective for β1- and β2-ARs, and with low affinity for the β3-AR subtype. It is a precursor to Pindolol and is used to study primary and renal vascular hypertension.

Bopindolol is an orally active antagonist of β-adrenoceptors (ARs) with partial agonist activity. Bopindolol is non-selective for β1- and β2-ARs and has low affinity for β3-AR subtype. Bopindolol is a prodrug of pindolol and can be rapidly metabolized to an active hydrolyzed form. Bopindolol can be used for essential and renovascular hypertension research [1] [2].

5-HT1A/1B antagonist and β-adrenoceptor antagonist

Espindolol, a β-adrenoceptor antagonist, is used potentially for the treatment of cachexia related to cancer.

Bopindolol is a non-selective β-adrenergic receptor antagonist. In vivo, bopindolol decreases heart rate and blood pressure and attenuates ischemia-induced myocardial acidosis in dogs. Formulations containing bopindolol have been used to treat essential and renovascular hypertension.

Cyanopindolol fumarate is a 5-HT receptor antagonist [1].

Cyanopindolol is a β3-adrenergic receptor antagonist that also acts as a potent and selective antagonist at presynaptic serotonin autoreceptors in the rat cerebral cortex. It exhibits binding affinity for 5-HT1A and 5-HT1B receptors (Ki: 2.1 nM and 3 nM, respectively).